International guide to social media launched by TranslateMedia
September 28, 2012Medical Communications
TranslateMedia, the international translation agency, has created an international guide to social media, to help agencies navigate social media use …
Boehringer’s Engelbert Tjeenk Willink leaves firm
September 28, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Engelbert Tjeenk Willink
Boehringer Board member Engelbert Tjeenk Willink, responsible for Marketing and Sales of Prescription Medicines, has decided to leave at the …
Two hepatitis C drugs win Prix Galien
September 28, 2012Medical Communications, Sales and Marketing Incivo, Janssen, MSD, Victrelis, prix galien
Two new hepatitis C drugs have been given the 2012 UK Prix Galien innovative product award as joint winners in …
Vertex abandons hep C drug
September 27, 2012Research and Development, Sales and Marketing Alios BioPharma, Vertex, hep C
Vertex Pharmaceutical’s pipeline has been dealt a blow with the abandonment of an investigational hepatitis C compound. The US firm, …
CCG warning for doctors from BMA
September 27, 2012Sales and Marketing BMA, CCG, NHS, doctors
GPs have been urged to scrutinise the small print of the new clinical commissioning group (CCG) constitutions before they sign …
GlaxoSmithKline announces Board changes
September 27, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Witty
GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …
Roche unveils New York research base
September 26, 2012Research and Development New York, Nutley, Roche, translational research
Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards …
Trajenta added to insulin recommended in Europe
September 26, 2012Sales and Marketing Boehringer Ingelheim, Trajenta, diabetes
The CHMP has recommended that Boehringer Ingelheim and Eli Liily and Co’s diabetes brand Trajenta should be approved as add-on …
Sanofi to cut 900 jobs in France
September 26, 2012Research and Development Jobs, Sanofi, pharma job cuts, restructuring
Sanofi is to cut 900 jobs in its French operations by 2015 – fewer than expected after widespread speculation this …
Novo Nordisk to expand Beijing R&D centre
September 25, 2012Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D
Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …
Boehringer closing Petersburg API plant
September 25, 2012Manufacturing and Production API, Boehringer, Petersburg, chemicals
Boehringer Ingelheim has decided to close down one of its active pharmaceutical ingredient (API) manufacturing facilities in the US because …
Pharma is recovering, says Moody’s
September 25, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Moody's, Plavix, austerity, generics, pharma
Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …
Life Healthcare Communications appoints Lyndsey Wright
September 25, 2012Business Services, Medical Communications, Sales and Marketing Life healthcare communications, Lyndsey Wright
Life Healthcare Communications has expanded its client services department to meet demand with the appointment of a new senior account …
Eisai opens Fycompa UK manufacturing line
September 25, 2012Manufacturing and Production, Sales and Marketing Eisai, Fycompa
Eisai has opened a new solid dose production line for epilepsy drug Fycompa at its UK base in Hatfield, Hertfordshire. …
John LaMattina: Why was bapineuzamab moved into Phase III trials?
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, John LaMattina, Pfizer, bapineuzamab
The recent news that the Pfizer/J&J Alzheimer’s Disease drug, bapineuzumab (bapi), had failed in critical clinical trials resulted in great …
Contract research news in brief
September 24, 2012Research and Development AMRI, Celerion, Covance, GNS Healthcare, INC Research, Knopp Biosciences, PPD, Vitalea Bioscience
A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, Celerion, PPD, INC Research and …
EC publishes trio of revised GMP Guide sections
September 24, 2012Manufacturing and Production EC, EU, GMP, ICH
The European Commission has published two revised chapters in its Good Manufacturing Practice (GMP) Guide, along with an update of …
Eliquis receives nod in AF
September 24, 2012Sales and Marketing BMS, CHMP, Eliquis, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer have received a boost with the CHMP’s recommendation that their co-marketed oral anticoagulant Eliquis should gain …
CMO market on the up says new study
September 24, 2012Manufacturing and Production API, CMO, manufacturing
The global contract manufacturing market is expected to reach a value of nearly $48 billion this year on the back …
Amgen names Ray Jordan senior VP Corporate Affairs
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan
Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
